000193334 000__ 01558fam\a2200349\a\4500
000193334 001__ 193334
000193334 005__ 20220217103807.0
000193334 008__ 960322s1996\\\\dcu\\\\\\\\\\f000\0\eng\d
000193334 020__ $$a0160523168
000193334 035__ $$a(OCoLC)ocm34433649
000193334 035__ $$9(IS)ACX0746
000193334 035__ $$9AAW2618SI
000193334 035__ $$a193334
000193334 040__ $$aGPO$$cGPO
000193334 043__ $$an-us---
000193334 049__ $$aISUM
000193334 074__ $$a1019-A-01
000193334 074__ $$a1019-B-01 (MF)
000193334 0860_ $$aY 4.C 73/8:104-51
000193334 088__ $$aSerial no. 104-51 (United States. Congress. House. Committee on   Commerce)
000193334 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Commerce.$$bSubcommittee on Oversight and Investigations.
000193334 24510 $$aAllegations of FDA abuses of authority :$$bhearing before the      Subcommittee on Oversight and Investigations of the Committee on Commerce,      House of Representatives, One Hundred Fourth Congress, first session, July 25,  November 15, and December 5, 1995.
000193334 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1996.
000193334 300__ $$av, 344 p. ;$$c24 cm.
000193334 500__ $$aDistributed to some depository libraries in microfiche.
000193334 500__ $$aShipping list no.: 96-0150-P.
000193334 500__ $$a"Serial no. 104-51."
000193334 504__ $$aIncludes bibliographical references.
000193334 61010 $$aUnited States.$$bFood and Drug Administration$$vRules and       practice.
000193334 61010 $$aUnited States.$$bFood and Drug Administration$$xManagement.
000193334 61010 $$aUnited States.$$bFood and Drug Administration$$xOfficials and   employees.
000193334 85230 $$bdfich$$hY 4.C 73/8:$$i104-51
000193334 909CO $$ooai:library.usi.edu:193334$$pGLOBAL_SET
000193334 948__ $$ac:jb
000193334 980__ $$aBIB
000193334 980__ $$aGOV RESOURCE